This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
Source of effectiveness data
The effectiveness data were derived from a single study.
Link between effectiveness and cost data
The costing was carried out prospectively on the same sample of patients as that used in the effectiveness study.
Study sample
The following information was supplemented by a complementary paper, details of which were published elsewhere (see Other Publications of Related Interest). The use of power calculations to estimate the influence of chance on the results was not reported. The patients were recruited from general practices in England and Wales if they reported at least two headaches per month. The authors did not report any further inclusion criteria, or mention any exclusion criteria. This sample was appropriate for the clinical question since it comprised patients in whom acupuncture might be used. In addition, the patients were not selected according to their preference for acupuncture. The base-case costeffectiveness estimates included only those patients for whom there were complete health-related quality of life
Study design
The basis of the analysis was a randomised controlled trial. The unit and method of randomisation were not reported. The study was conducted at multiple primary care practices across England and Wales. The patients received treatment for 3 months and were then followed for a further 9 months, giving a time horizon of 12 months. A total of 146 patients did not supply complete HRQoL data and this represented the only element of loss to follow-up reported. Blinding was not possible from the perspective of either the patient or acupuncturist. The authors did not report whether the analysts were blinded.
Analysis of effectiveness
The analysis was carried out on an intention to treat basis. The primary health outcomes were contact time with the acupuncturist, and HRQoL at baseline and 3 and 12 months. HRQoL is reported in the 'Measure of Benefits Used in the Economic Analysis" section. The authors reported that the baseline characteristics for the patients in the two arms were "similar".
Effectiveness results
Patients in the acupuncture arm had on average 4.2 hours of contact with the acupuncturist. See "Estimated Benefits Used in the Economic Analysis" section for a summary of the quality-adjusted life-year (QALY) results.
Clinical conclusions
The authors concluded that there was an improvement in QALYs during the 12 months in the acupuncture group, but not in the control group. This improvement was statistically significant.
Modelling
A linear regression model was used to explore differences between the two study groups in terms of the cost and effectiveness.
Measure of benefits used in the economic analysis
The summary measure of benefit was the QALYs. These were estimated from the SF-36 questionnaire, which was completed by the study sample at baseline and 3 and 12 months, the results of which were transformed into the SF-6D using an algorithm.
Direct costs
The direct costs included both the costs to the health service and patients. Discounting was not required since the time horizon was 12 months. The cost estimation centred on the cost of the acupuncture sessions, other health care professional visits and "other" such as over-the-counter medication. The patients were asked to report unit costs associated with non-prescription drugs and private health care visits. The unit costs for the study intervention were estimated from published sources and multiplied by the quantities observed in the clinical study. The costs were measured for 2002-03 and then inflated to 2003 prices.
Statistical analysis of costs
SDs and confidence intervals (CIs) were reported in order to estimate uncertainty in the total cost estimates and to derive cost-effectiveness acceptability curves.
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Indirect Costs
The indirect costs relating to the time off work (a measure of productivity loss) due to morbidity were estimated.
Currency
UK pounds sterling ().
Sensitivity analysis
Sensitivity analyses were conducted to test the robustness of the results to changes in the base-case assumptions:
the staff time and grade associated with acupuncture treatment; the impact of including productivity loss; different strategies to deal with missing data; and different time horizons, using discount rates of 6% for costs and 1.5% for QALYs.
Estimated benefits used in the economic analysis
The QALYs were 0.727 (SD=0.119) in the acupuncture arm and 0.708 (SD=0.112) in the control arm. The mean difference was 0.021 (95% CI: 0.001 -0.040).
Cost results
The cost to the National Health Service (NHS) was 289. 
Synthesis of costs and benefits
The incremental cost per QALY gained was 9,951 from the NHS perspective, 9,180 from the total cost perspective, and 3,263 from the societal perspective.
